We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand Empliciti (elotuzumab) side effects, a targeted therapy for multiple myeloma. Learn about common reactions like fatigue, diarrhea, and serious risks such as infections and liver problems. Get expert advice on management, when to see a doctor, and essential FAQs for patients and caregivers.
Empliciti (elotuzumab) is a targeted therapy medication used in combination with other drugs to treat multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. While Empliciti can be an effective treatment, like all medications, it comes with a range of potential side effects. Understanding these side effects, knowing what to look for, and when to seek medical attention is crucial for anyone undergoing treatment with Empliciti, as well as their caregivers.
This comprehensive guide aims to provide detailed information on the common and serious side effects associated with Empliciti. We will explore how Empliciti works, why certain side effects occur, and practical strategies for managing them. Armed with this knowledge, you can better communicate with your healthcare team and ensure the safest and most effective treatment journey possible.
Empliciti, also known by its generic name elotuzumab, is a type of monoclonal antibody. It works by targeting a specific protein called Signaling Lymphocytic Activation Molecule Family member 7 (SLAMF7), which is found on the surface of multiple myeloma cells and also on natural killer (NK) cells, a type of immune cell. By binding to SLAMF7 on myeloma cells, Empliciti helps the immune system, particularly NK cells, to recognize and destroy these cancer cells. It also enhances the activity of other anti-myeloma treatments.
Empliciti is typically administered intravenously (into a vein) in combination with other anti-myeloma drugs, such as lenalidomide and dexamethasone, or pomalidomide and dexamethasone. Its targeted mechanism of action means it focuses on cancer cells, but it can still affect healthy cells or trigger immune responses that lead to various side effects.
Many people receiving Empliciti will experience some side effects, most of which are mild to moderate and manageable. It's important to report any new or worsening symptoms to your healthcare provider, even if they seem minor.
Infusion-related reactions are among the most common side effects, occurring during or within 24 hours of an Empliciti infusion. These reactions happen because your immune system reacts to the medication being introduced into your body. To help prevent or lessen IRRs, your doctor will likely prescribe pre-medications, such as corticosteroids (like dexamethasone), antihistamines (like diphenhydramine), and acetaminophen (Tylenol), to be taken before each infusion.
Fatigue is a pervasive side effect of many cancer treatments, including Empliciti. It's more than just feeling tired; it's an overwhelming sense of exhaustion that isn't relieved by rest and can significantly impact daily activities.
Diarrhea is a common gastrointestinal side effect that can lead to dehydration and electrolyte imbalances if not managed properly.
Nausea, with or without vomiting, can significantly affect appetite and quality of life.
While diarrhea is more common, some patients may experience constipation, especially if also taking opioid pain medications or experiencing dehydration.
A low-grade fever can be a common side effect, but it's crucial to monitor for higher fevers as they can indicate an infection.
Due to its impact on the immune system, Empliciti can increase the risk of infections, including common URTIs.
A cough can be part of an URTI or a standalone symptom.
Peripheral neuropathy involves damage to nerves outside the brain and spinal cord, leading to changes in sensation, usually in the hands and feet.
Reduced appetite can be a consequence of nausea, fatigue, or the disease itself, potentially leading to unintended weight loss.
Empliciti, especially in combination with other chemotherapy agents, can affect bone marrow function, leading to reduced production of blood cells.
While less common, some side effects of Empliciti can be serious or life-threatening and require immediate medical attention. It is vital to be aware of these and know when to seek urgent care.
While most IRRs are mild, some can be severe, including anaphylaxis, a life-threatening allergic reaction.
Because Empliciti can weaken the immune system, patients are at an increased risk of developing serious infections, including bacterial, viral, and fungal infections, which can sometimes be fatal.
There is an increased risk of developing secondary primary malignancies (new cancers) in patients treated with Empliciti in combination with lenalidomide and dexamethasone. These can include skin cancers (basal cell carcinoma, squamous cell carcinoma) and other solid tumors.
Empliciti can, in rare cases, cause liver damage or abnormal liver function.
PML is a rare but very serious and often fatal brain infection caused by the John Cunningham (JC) virus. It can occur in patients with weakened immune systems, including those on Empliciti.
It’s crucial to maintain open communication with your healthcare team throughout your Empliciti treatment. Do not hesitate to contact them if you experience any concerning symptoms. Here’s a guide on when to seek medical advice:
Proactive management and close collaboration with your healthcare team are key to minimizing the impact of Empliciti side effects and maintaining your quality of life.
Always take your prescribed pre-medications (corticosteroids, antihistamines, acetaminophen) exactly as instructed before each Empliciti infusion. These medications are crucial for reducing the risk and severity of IRRs.
Your healthcare team will conduct regular blood tests (e.g., complete blood counts, liver function tests) to monitor for potential side effects and adjust your treatment as needed. Attend all scheduled appointments.
Adequate fluid intake is vital, especially with diarrhea or fever. A balanced, nutritious diet supports your immune system and overall well-being. Consult with a dietitian if you are struggling with appetite or weight loss.
Be honest and detailed when describing your symptoms. Keep a symptom diary to track when side effects occur, their severity, and what helps alleviate them. This information is invaluable to your doctor in managing your care.
Gentle exercise, stress-reduction techniques (e.g., meditation, deep breathing), and adequate sleep can help improve overall well-being and cope with treatment side effects.
It is essential to inform your doctor about all medications you are currently taking, including prescription drugs, over-the-counter medications, herbal supplements, and vitamins. This helps your healthcare team assess potential drug interactions that could alter Empliciti's effectiveness or increase the risk of side effects.
Empliciti is not recommended for use during pregnancy as it may harm a developing fetus. Women of childbearing potential should use effective contraception during treatment and for at least 4 months after the last dose. It is also not known if Empliciti passes into breast milk, so breastfeeding is not recommended during treatment and for at least 4 months after the last dose.
The safety and effectiveness of Empliciti in pediatric patients have not been established.
Clinical studies have shown that Empliciti is generally well-tolerated in elderly patients, but older adults may be more susceptible to certain side effects or have pre-existing conditions that require careful monitoring.
Individuals with certain pre-existing conditions, such as liver or kidney impairment, or those with a history of recurrent infections, may require closer monitoring or dose adjustments. Always provide your complete medical history to your healthcare provider.
A1: Empliciti (elotuzumab) is a targeted therapy, specifically a monoclonal antibody. While it treats cancer, it works differently from traditional chemotherapy, which broadly attacks rapidly dividing cells. Targeted therapies aim at specific molecules involved in cancer cell growth and survival, often leading to a different side effect profile. However, Empliciti is frequently used in combination with chemotherapy-like drugs or other immunomodulatory agents.
A2: The duration of side effects can vary greatly. Infusion-related reactions typically occur during or shortly after the infusion. Other side effects like fatigue, nausea, or low blood counts may persist for days or weeks after an infusion, or even throughout the treatment course. Some serious side effects, if they occur, can have long-lasting implications. Always discuss the persistence of any side effect with your healthcare provider.
A3: Always consult your doctor or pharmacist before taking any over-the-counter medications, herbal remedies, or supplements while on Empliciti. Some products can interact with Empliciti or other medications you are taking, potentially causing adverse effects or reducing treatment effectiveness.
A4: Hair loss (alopecia) is not a commonly reported side effect of Empliciti (elotuzumab) itself. However, because Empliciti is often used in combination with other anti-cancer drugs, some of which are known to cause hair loss (e.g., certain chemotherapy agents), you might experience hair thinning or loss depending on your full treatment regimen. Discuss this concern with your oncology team.
A5: If you miss an appointment for your Empliciti infusion, contact your healthcare team immediately. They will advise you on rescheduling your dose and adjusting your treatment schedule as necessary. Do not try to double up on doses or adjust your schedule without medical guidance.
A6: The impact of Empliciti on fertility in humans is not fully established. However, given its potential to affect rapidly dividing cells and its classification as potentially harmful during pregnancy, it's prudent for patients of reproductive age to discuss fertility preservation options with their doctor before starting treatment, if this is a concern. Always use effective contraception during treatment and for a period afterward, as advised by your doctor.
Empliciti offers a valuable treatment option for individuals battling multiple myeloma, significantly improving outcomes for many patients. However, understanding and proactively managing its potential side effects is an integral part of a successful treatment journey. From common infusion-related reactions and fatigue to more serious concerns like infections and rare neurological complications, being informed empowers you to recognize symptoms early and seek timely medical attention.
Remember, your healthcare team is your most important resource. Maintain open and honest communication, report all symptoms, and follow their guidance diligently. By working together, you can navigate the challenges of treatment, minimize discomfort, and focus on your health and well-being.

Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026

Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026